Volume scattering of distributed microbubbles and its influence on blood flow estimation

A consistent tissue attenuation coefficient estimator using bubble harmonic echoes

The ultrasonic property of soft tissue can be quantified by its attenuation coefficient α. Traditionally the backscattering signal of tissue is used to estimate α. To improve precision, a large number of spatially independent samples of tissue echoes are required for averaging. In this paper, we propose a new estimation method, which makes use of microbubbles to provide temporally independent samples for averaging. It is easier for temporal sampling to maintain ergodicity and provide a large number of independent samples for statistical averaging. A stochastic model for the harmonic signals of an ideal bubble attenuated by tissue is derived based on Kuc's and Miller's works. An estimator of α is then presented. This estimator is consistent and could be biased because of the unknown squarelaw relation between the second and fundamental harmonics for non-ideal bubble oscillation. In experimental works, we design a simplified phantom for demonstrating the performance of the proposed estimator. It is shown that both first and second harmonics can estimate α consistently. However, the interference of the tissue backscattering signal may cause additional estimation error using the first harmonic.

Effects of Ultrasound Contrast Agents on Doppler Tissue Velocity Estimation

The combination of Doppler tissue imaging and myocardial contrast echocardiography has the potential to provide information about motion and perfusion of the myocardium in a single examination. The purpose of this study was to establish how the presence of ultrasound contrast agent (UCA) affects measurements of Doppler tissue velocities in vivo and in vitro. We performed echocardiography in 12 patients with ischemic heart disease before and immediately after a slow intravenous infusion of the UCA Optison, using color Doppler tissue imaging to examine the effect of contrast agents in vivo. The myocardial peak systolic velocities and their integrals were analyzed in digitally stored cineloops before and after contrast administration. To distinguish between methodologic and physiologic factors affecting the measurement of tissue velocity in vitro, experiments with a rotating disk and a flow cone phantom were also carried out for the 3 contrast agents: Optison, Sonovue, and Sonazoid. In vivo results show that the values for peak systolic velocity increased by about 10% during contrast infusion, from mean 5.2 +/- 1.8 to 5.7 +/- 2.3 cm/s (P = .02, 95% confidence interval 2%-16%). The increase in myocardial peak systolic velocities was verified in experimental models in which the UCA increased the estimated mean velocity in the order of 5% to 20% for the motion interval of 5 to 7 cm/s, corresponding to the myocardial velocities studied in vivo. The response was similar for all 3 contrast agents and was not affected by moderate variations in concentration of the agent. We have shown that the presence UCA will affect Doppler tissue measurements in vivo and in vitro. The observed bias is presumed to be an effect of harmonic signal contribution from rupturing contrast agent microbubbles and does not indicate biologic or physiologic effects.